BRAF (alternately referred to as v-raf murine sarcoma viral oncogene homolog B1) is a proto-
oncogene involved in the mitogen-activated protein kinase (MAPK) pathway. BRAF …

Background Pleomorphic xanthoastrocytoma (PXA) is a rare low-grade brain tumor. To date,
limited studies have analyzed factors affecting survival outcomes and defined the …

Aims Anaplastic ganglioglioma is a rare tumour, and diagnosis has been based on
histological criteria. The 5th edition of the World Health Organization Classification of …

The BRAF gene and the TERT promoter are among the most frequently altered genomic loci
in low-grade (LGG) and high-grade-glioma (HGG), respectively. The coexistence of BRAF …

Abstract Introduction Pleomorphic xanthoastrocytomas (PXAs) are classified as a grade II
neoplasm, typically occur in children, and have favorable prognoses. However, their …

Pleomorphic xanthoastrocytomas (PXA) are rare, accounting for< 1% of all astrocytomas.
Literature on the clinical course and treatment outcomes of PXAs is limited. The study aimed …

Objectives Seeking a noninvasive predictor for BRAF V600E mutation status of pleomorphic
xanthoastrocytomas (PXAs) is essential for their prognoses and therapeutic use of BRAF …

Background Pleomorphic xanthoastrocytomas (PXA) are circumscribed gliomas that
typically have a favorable prognosis. Limited studies have revealed factors affecting survival …

Many breakthroughs have been made in the past decade regarding our knowledge of the
biological basis of the diffuse gliomas, the most common primary central nervous system …

Purpose: Pleomorphic xanthoastrocytoma (PXA) is an uncommon astrocytoma that tends to
occur in children and young adults and has a relatively favorable prognosis. The 2021 WHO …